Sagimet Biosciences Inc. (SGMT) stock
SGMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.22−0.71 (-6.50%)
Close on Nov 13, 2026Market cap $635.26MP/E –Yield –
Sagimet Biosciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Sagimet Biosciences's profit margin for the twelve months ending Dec 31, 2023 was -1393.8%. For fiscal 2023 it was -1393.8%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -1393.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | -317.6% | – |
See a number that looks wrong?